v3.26.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Income Statement [Abstract]    
License and other revenue $ 0 $ 15,000
Operating expenses:    
Research and development 59,891 33,443
General and administrative 19,882 12,334
Loss from operations (79,773) (30,777)
Interest and investment income 5,138 7,890
Interest expense (2,731) (2,877)
Other non-operating income (expense), net (1,025) 1,026
Loss before income taxes (78,391) (24,738)
Income tax expense 850 1,397
Net loss (79,241) (26,135)
Other comprehensive (loss) income:    
Foreign currency translation adjustment (580) 643
Unrealized (loss) gain on available for sale securities during period, net of tax of $0.2 million in 2026 and $0 in 2025 (483) 6
Reclassification adjustment for realized net (loss) gain on available for sale marketable securities included in net loss, net of tax of $0.1 million in 2026 and $0.8 million in 2025 (243) (2,787)
Other comprehensive (loss) income (1,306) (2,138)
Total comprehensive loss $ (80,547) $ (28,273)
Net loss per ordinary share - basic (in USD per share) $ (0.52) $ (0.20)
Net loss per ordinary share - diluted (in USD per share) $ (0.52) $ (0.20)
Weighted average ordinary shares outstanding - basic (in shares) 153,549,733 133,033,541
Weighted average ordinary shares outstanding - diluted (in shares) 153,549,733 133,033,541